 |
The
sensory Nerve Conduction Threshold (sNCT) evaluation and screening for
Carpal Tunnel Syndrome (CTS) begins with testing conducted at the distal phalange of the
index finger (B). Early CTS is associated with hyperesthetic CPTs
(abnormally low electrical excitability) reflecting inflamed nerves
(neuritis) that
have not lost their functioning. Advanced CTS, associated with a loss
of median nerve function (neuropathy), is associated with hypoesthetic (abnormally high)
CPTs. The combination of a sensory impairment detected at the distal
phalange of the index finger (Site B), combined with normal CPT measures
from the ulnar nerve (5th finger, Site E) and palmar branch of the median
nerve (Site I, pre-tunnel
control site),
objectively confirms the clinical
diagnosis of CTS. The CPT evaluation can detect CTS in the presence of a
polyneuropathy. This electrodiagnostic procedure confirms the recovery of
median nerve function following conservative or surgical treatment of CTS.
Screening for CTS in industrial settings results in the prevention of
advanced complications and significant financial savings.
Utilization Guidelines
Focal nerve lesions, such as
those induced by a traumatic injury, are evaluated and confirmed by
determining a normal sensory function proximal to the suspected lesion and
abnormal function distally. For example, evaluation of carpal tunnel
syndrome is performed by testing the median nerve proximal and distal to the
carpal tunnel - at the palmar cutaneous branch of the median nerve and the
distal digital branches of the median nerve, respectively. Upon obtaining
measures consistent with the suspected condition, the distal digital
branches of the ulnar nerve at the little finger are evaluated to rule out a
distal polyneuropathy mimicking or co-existing with carpal tunnel syndrome.
Excerpt from Recurrent Nerve
Compression: Around the Hand Table: Hand Surgery Quarterly, Winter
2005 pgs. 7-18. A Publication of the American Association for Hand Surgery.
Dr. Van Beek: "Ms. Collins, you use Neurometer screening both for initial
assessment and for follow up assessment, has that been a helpful adjunct in
advising patients? How do you use those screening Neurometers in the
management of the median neuropathies?"
Ms. Collins: "I was actually just going to interject because I think it’s
been a very helpful tool for us to have in the clinic. These tests are
non-invasive and are very convenient to use. They’re relatively comfortable
for the patient and you get objective information that you can use to
evaluate the patient’s status. We use it prior to surgery and for follow
ups. I think it is particularly helpful for showing the patient how he’s
doing during the post-surgery, healing/ rehab period."
The moderator for this discussion is Allen Van Beek, MD, in private practice
in Minneapolis, MN, and a professor for the Plastic Surgery training program
at the University of Minnesota.
He is joined by: Richard Brown, MD, FACS, Springfield Clinic, Clinical
Professor, Division of Plastic Surgery, Southern Illinois University,
Springfield, IL; Joan Collins, OTR/L, CHT, Collins Hand Therapy,
Minneapolis, MN; Neil Ford Jones, MD, FRCS, Professor and Chief of Hand
Surgery, Department of Orthopedic Surgery and Division of Plastic and
Reconstructive Surgery, UCLA Medical Center, Los Angeles, CA; Susan
Mackinnon, MD, Shoenberg Professor of Surgery, Chief, Division of Plastic
and Reconstructive Surgery, Washington University in St. Louis, School of
Medicine, St. Louis, MO; and Steven McCabe, MD, MSc, University of
Louisville, Louisville, KY.
(Cutaneous nerve illustration
on left by Frank Netter, MD)
See a selected bibliography of related publications using Neurometer
technology.
top of page
Previous page
Home |